MET and cancer: Met (mesenchymal endosomal transition) encodes a receptor tyrosine kinase, which is activated by hepatocyte growth factor (HGF) and thereby involved in the regulation of a variety of biological processes including cell motility, cell proliferation, the epithelial-to-mesenchymal transition, and the development and progression of cancer cells [17].